Back to LRMR
GOLDMAN SACHS GROUP INC → LRMR
GOLDMAN SACHS GROUP INC LRMR Position History
Larimar Therapeutics, Inc. • Healthcare
Quarters held
18
Latest value
$182K
Q2 2026
Peak value
$5.2M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $244K |
| Q2 2025 | $137K |
| Q3 2025 | $3.6M |
| Q3 2025 | $1.4M |
| Q3 2025 | $58K |
| Q4 2025 | $68K |
| Q4 2025 | $2.1M |
| Q4 2025 | $2.9M |
| Q4 2025 | $2.9M |
| Q4 2025 | $2.1M |
| Q4 2025 | $68K |
| Q1 2026 | $4.6M |
| Q1 2026 | $405K |
| Q1 2026 | $2.4M |
| Q1 2026 | $76K |
| Q2 2026 | $5.2M |
| Q2 2026 | $275K |
| Q2 2026 | $182K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $182K | 59.5K | — | — |
| Q2 2026 | $275K | 90.0K | — | — |
| Q2 2026 | $5.2M | 1.69M | — | — |
| Q1 2026 | $76K | 16.8K | — | — |
| Q1 2026 | $2.4M | 528.9K | — | — |
| Q1 2026 | $405K | 90.0K | — | — |
| Q1 2026 | $4.6M | 1.02M | — | — |
| Q4 2025 | $68K | 18.0K | — | — |
| Q4 2025 | $2.1M | 558.6K | — | — |
| Q4 2025 | $2.9M | 770.6K | — | — |
| Q4 2025 | $2.9M | 770.6K | — | — |
| Q4 2025 | $2.1M | 558.6K | — | — |
| Q4 2025 | $68K | 18.0K | — | — |
| Q3 2025 | $58K | 18.0K | — | — |
| Q3 2025 | $1.4M | 427.5K | — | — |
| Q3 2025 | $3.6M | 1.13M | — | — |
| Q2 2025 | $137K | 47.4K | — | — |
| Q2 2025 | $244K | 84.3K | — | — |